
To compare the efficacy and safety of basal insulin glargine 100 units/mL (Gla) + 2‐3 oral antihyperglycaemic drugs (OADs) with twice‐daily premixed insulin aspart 70/30 (Asp30) + metformin (MET) after short‐term intensive insulin therapy in adults with type 2 diabetes in China. Compared with Asp30 + MET, Gla +2‐3 OADs showed similar efficacy but lower hypoglycaemia risk in Chinese individuals with type 2 diabetes who had undergone short‐term intensive insulin therapy.
Like
Save
Share